首頁
> 研究成果
> 2022年
> Clinical outcomes and metastatic behavior between de novo versus recurrent HER2-postive metastatic breast cancer: A 17-year single-institution cohort study at Taipei Veterans General Hospital
Clinical outcomes and metastatic behavior between de novo versus recurrent HER2-postive metastatic breast cancer: A 17-year single-institution cohort study at Taipei Veterans General Hospital
